JP4731610B2 - W / O / W type composite emulsion - Google Patents
W / O / W type composite emulsion Download PDFInfo
- Publication number
- JP4731610B2 JP4731610B2 JP2009053630A JP2009053630A JP4731610B2 JP 4731610 B2 JP4731610 B2 JP 4731610B2 JP 2009053630 A JP2009053630 A JP 2009053630A JP 2009053630 A JP2009053630 A JP 2009053630A JP 4731610 B2 JP4731610 B2 JP 4731610B2
- Authority
- JP
- Japan
- Prior art keywords
- polyoxyethylene
- fatty acid
- acid ester
- hydrophilic
- aqueous phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Description
本発明は、医薬用や化粧料製剤等として有用なW/O/W型複合エマルションに関する。 The present invention relates to a W / O / W type composite emulsion useful as a pharmaceutical or cosmetic preparation.
W/O/W型複合エマルションを生成させるためには、分散質となるW/O型エマルションを調製した後、該W/O型エマルションを外水相に再分散させる必要がある。
しかし、再分散の過程で、W/O型エマルションの油相の一部が外水相中の親水性界面活性剤によって可溶化されるため、W/O型エマルションは破壊されやすく、結果として安定性に優れたW/O/W型複合エマルションを高い生成率で得ることが困難であった。従来、このような再分散工程(2次乳化)中の転相を防止するために、1次乳化で内水相に対して油相の割合を高めたW/O型エマルション(W≦O)の調製が不可欠であった。しかし、内水相に対して油相の割合を高めたW/O型エマルションを用いると、べたつき感が生じ、W/O/W型本来の使用感が損なわれる問題があった。
また、W/O/W型複合エマルションは、高い生成率で調製することが難しいばかりでなく、長期安定性、特に凍結復元性が著しく劣る問題がある。従来、W/O/W型複合エマルションの安定化方法がいくつか提案されているが、良好な使用感と長期安定性特に凍結復元性を同時に解決する手段はなかった。すなわち、高い生成率でW/O/W型複合エマルションを製造する従来技術例として、複合粒子(W/O粒子)同士の合一を防ぐ方法として、特許文献1に、外水相に増粘剤として水溶性多糖類を使用する方法が記載されている。しかしながら、この方法では内水相の合一は防げず、安定化不十分であり、しかも増粘するので使用感が損なわれ、実用的でない。また、特許文献2には、硫酸化多糖を配合したW/O型乳化組成物が開示されている。しかしながら、この方法では長期安定性(エマルションの粘度維持)が不十分であるばかりでなく、外相が油であるためべたつき感があり実用的でない。
さらに、特許文献3には、内水相に単糖類、二糖類、多糖類及び多価アルコールから選ばれる1種以上を含有するW/O/W型乳化香料組成物が開示されている。しかしながら、この方法では安定化のために上記成分を多量に配合しなくてはならず実用的ではない。
In order to produce a W / O / W type composite emulsion, it is necessary to prepare a W / O type emulsion as a dispersoid and then redisperse the W / O type emulsion in the outer aqueous phase.
However, part of the oil phase of the W / O emulsion is solubilized by the hydrophilic surfactant in the outer aqueous phase during the redispersion process, so the W / O emulsion is easily broken and consequently stable. It was difficult to obtain a W / O / W type composite emulsion excellent in properties at a high production rate. Conventionally, in order to prevent such phase inversion during the redispersion process (secondary emulsification), W / O emulsion (W ≦ O) in which the ratio of the oil phase to the inner aqueous phase is increased by primary emulsification. The preparation of was essential. However, when a W / O type emulsion having a higher ratio of the oil phase to the inner aqueous phase is used, there is a problem that a sticky feeling is generated and the original feeling of use of the W / O / W type is impaired.
Further, the W / O / W type composite emulsion is not only difficult to prepare at a high production rate, but also has a problem that the long-term stability, particularly freeze-recoverability, is remarkably inferior. Conventionally, several methods for stabilizing W / O / W type composite emulsions have been proposed. However, there has been no means for simultaneously solving good usability and long-term stability, particularly freeze-recoverability. That is, as a prior art example for producing a W / O / W type composite emulsion with a high production rate, as a method for preventing coalescence of composite particles (W / O particles), Patent Document 1 discloses a thickening in an external water phase. A method of using a water-soluble polysaccharide as an agent is described. However, this method cannot prevent coalescence of the inner aqueous phase, is insufficiently stabilized, and further increases the viscosity, impairing the feeling of use and is not practical. Patent Document 2 discloses a W / O type emulsion composition containing a sulfated polysaccharide. However, this method not only has insufficient long-term stability (maintenance of emulsion viscosity), but also has a sticky feeling because the outer phase is oil, and is not practical.
Further, Patent Document 3 discloses a W / O / W emulsified fragrance composition containing one or more selected from monosaccharides, disaccharides, polysaccharides and polyhydric alcohols in the inner aqueous phase. However, in this method, a large amount of the above components must be blended for stabilization, which is not practical.
本発明は、長期安定性、特に凍結復元性及び使用感に優れたW/O/W型複合エマルションを提供する。 The present invention provides a W / O / W type composite emulsion that is excellent in long-term stability, in particular, freezing and restoring property and usability.
本発明は、分子内にスルホン基及び/又はカルボキシル基を有する多糖類を内水相に配合することにより、2次乳化で破壊されにくい安定な高含水W/O型エマルションの調製が可能であることを見出し、前記W/O型エマルションを分散質とすることによって、長期安定性、特に凍結復元性に優れるW/O/W型複合エマルションが高い生成率で得られることを見出したものである。
すなわち、本発明は、分子内にスルホン基及び/又はカルボキシル基を有する多糖類を内水相に含有することを特徴とするW/O/W型複合エマルションを提供する。
In the present invention, a stable high water content W / O emulsion that is difficult to be destroyed by secondary emulsification can be prepared by blending a polysaccharide having a sulfone group and / or a carboxyl group in the molecule with the inner aqueous phase. It has been found that by using the W / O emulsion as a dispersoid, a long-term stability, in particular, a W / O / W composite emulsion having excellent freezing and restoring properties can be obtained with a high production rate. .
That is, the present invention provides a W / O / W type composite emulsion characterized in that a polysaccharide having a sulfone group and / or a carboxyl group in the molecule is contained in the inner aqueous phase.
本発明の多糖類を構成する主な単糖としては、D-グルコサミン、D-ガラクトサミン、D-グルクロン酸、L-イズロン酸、D-グルコース、D-ガラクトース、D-キシロース等があげられる。本発明の多糖類は、1種以上の単糖のポリマーであり、スルホン基又はカルボキシル基は、単糖1分子あたり平均0.4〜5分子含まれるのが好ましく、より好ましくは0.5〜3分子、さらに好ましくは0.6〜2分子含まれるのが好ましい。本発明の多糖類の平均分子量は、好ましくは1,000〜10,000,000、より好ましくは3,000〜1,000,000、さらに好ましくは5,000〜500,000である。 Main monosaccharides constituting the polysaccharide of the present invention include D-glucosamine, D-galactosamine, D-glucuronic acid, L-iduronic acid, D-glucose, D-galactose, D-xylose and the like. The polysaccharide of the present invention is a polymer of one or more monosaccharides, and the sulfone group or carboxyl group is preferably contained in an average of 0.4 to 5 molecules per monosaccharide molecule, more preferably 0.5 to 3 molecules, Preferably 0.6 to 2 molecules are contained. The average molecular weight of the polysaccharide of the present invention is preferably 1,000 to 10,000,000, more preferably 3,000 to 1,000,000, and still more preferably 5,000 to 500,000.
このような多糖類としては、ヒアルロン酸、コンドロイチン4-硫酸、コンドロイチン6-硫酸、デルマタン硫酸、ケラタン硫酸、ヘパリン、ヘパリン類似物質(日本薬局方外医薬品規格収載)、カッパ−、イオタ−又はラムダ−カラギーナン、ダービリアエキス等の酸性ムコ多糖類;キチン等の中性ムコ多糖類を硫酸化したものがあげられる。このうち、酸性ムコ多糖類が好ましく、特にコンドロイチン4-硫酸、ヘパリン、ヘパリン類似物質、イオタ−カラギーナン、ヒアルロン酸が好ましい。
本発明の多糖類は、天然物および合成物に関わらず使用でき、単独で使用しても2種以上を併用することもできる。
本発明の多糖類の配合量は内水相の全質量に対して好ましくは0.02〜3%、より好ましくは0.2〜2%、さらに好ましくは0.7〜1.5%である。本発明のW/O/W型複合エマルションの全質量に対しては、好ましくは0.01〜2%、より好ましくは0.03〜1.5%、さらに好ましくは0.05〜1%である。
Such polysaccharides include hyaluronic acid, chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate, keratan sulfate, heparin, heparin-like substances (listed in the Japanese Pharmacopoeia Standards for Drugs), kappa, iota, or lambda. Acid mucopolysaccharides such as carrageenan and dabilia extract; and sulfated neutral mucopolysaccharides such as chitin. Of these, acidic mucopolysaccharides are preferable, and chondroitin 4-sulfate, heparin, heparin-like substances, iota-carrageenan, and hyaluronic acid are particularly preferable.
The polysaccharide of the present invention can be used regardless of natural products and synthetic products, and can be used alone or in combination of two or more.
The blending amount of the polysaccharide of the present invention is preferably 0.02 to 3%, more preferably 0.2 to 2%, still more preferably 0.7 to 1.5% with respect to the total mass of the inner aqueous phase. Preferably it is 0.01-2% with respect to the total mass of the W / O / W type | mold composite emulsion of this invention, More preferably, it is 0.03-1.5%, More preferably, it is 0.05-1%.
本発明の油相としては、流動パラフィン、ワセリン、マイクロクリスタリンワックス、スクワラン等の炭化水素類、オリーブ油、サフラワー油、大豆油、アルモンド油、ヒマシ油等の植物油、ミツロウ、鯨ロウ、ラノリン等の動物性固体ロウ、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、ミリスチン酸オクチルドデシル、トリ(カプリル・カプリン酸)グリセリン等の脂肪酸エステル等、一般外用剤、化粧品に使用されているものであれば特に限定されることなく使用することができる。
本発明のW/O/W型複合エマルションは、好ましくは以下の方法により製造することができる。
(1)1次乳化
分子内にスルホン基及び/又はカルボキシル基を有する多糖類を含有する内水相成分溶液(好ましくは有効成分を含有する)と油相成分溶液(好ましくは親油性界面活性剤を含有する)を、65〜85℃、特に好ましくは70〜80℃に加温しそれぞれを均一溶解させる。溶解後、同温度条件下で油相成分をホモミキサー等で撹拌しながら、内水相/油相=50/50〜90/10、好ましくは60/40〜85/15、さらに好ましくは65/35〜80/20の質量比となるように内水相をゆっくり添加していきW/O型エマルションを調製する。攪拌条件は、攪拌羽根の大きさや乳化組成によって適宜選定されるが、概ね3000〜6000rpmの回転数で5〜20分間乳化することが好ましい。乳化物の電気伝導度がほとんどゼロ(外相が油)であることによってW/O型エマルションの生成を確認する。
Examples of the oil phase of the present invention include hydrocarbons such as liquid paraffin, petrolatum, microcrystalline wax, squalane, vegetable oils such as olive oil, safflower oil, soybean oil, almond oil, castor oil, beeswax, whale wax, lanolin and the like. Animal solid wax, isopropyl myristate, isopropyl palmitate, octyldodecyl myristate, fatty acid ester such as tri (caprylic / capric) glycerin, and the like are particularly limited as long as they are used in general external preparations and cosmetics. Can be used without
The W / O / W type composite emulsion of the present invention can be preferably produced by the following method.
(1) Primary emulsification An inner aqueous phase component solution (preferably containing an active ingredient) containing a polysaccharide having a sulfone group and / or a carboxyl group in the molecule and an oil phase component solution (preferably a lipophilic surfactant) Is heated to 65 to 85 ° C., particularly preferably 70 to 80 ° C., and each is uniformly dissolved. After dissolution, stirring the oil phase component with a homomixer or the like under the same temperature condition, the inner aqueous phase / oil phase = 50/50 to 90/10, preferably 60/40 to 85/15, more preferably 65 / The inner aqueous phase is slowly added so as to obtain a mass ratio of 35 to 80/20 to prepare a W / O type emulsion. The stirring conditions are appropriately selected depending on the size of the stirring blade and the emulsified composition, but it is preferable to emulsify for 5 to 20 minutes at a rotational speed of about 3000 to 6000 rpm. The formation of a W / O emulsion is confirmed by the fact that the electrical conductivity of the emulsion is almost zero (the outer phase is oil).
(2)2次乳化
45〜70℃、特に好ましくは50〜65℃の温度条件下で外水相溶液(好ましくは親水性界面活性剤を含有する)をホモミキサー等で撹拌しながら、(1)で得られたW/O型エマルションを、W/O型エマルション/外水相=30/70〜80/20、好ましくは40/60〜70/30、さらに好ましくは45/55〜60/40の質量比となるように外水相に添加していき、W/O/W型複合エマルションを調製する。乳化条件は、一度生成した複合粒子が破壊されないよう適宜選定することが好ましいが、概ね500〜3000rpmの回転数で20〜90分間乳化することが好ましい。
本発明の構成により、内水相を高含水化することが可能である。分散質となるW/O型エマルションの内水相と油相の混合質量比は、内水相/油相=好ましくは50/50〜90/10、より好ましくは60/40〜85/15、さらに好ましくは70/30〜80/20が望ましい。この範囲で、好ましい製剤の使用感が得られるので好ましい。
このW/O型エマルションと分散媒である外水相の質量比は、W/O型エマルション/外水相=好ましくは30/70〜80/20、より好ましくは40/60〜70/30、さらに好ましくは45/55〜60/40が望ましい。この範囲で、本発明のエマルションの生成率および安定性が良好であるので好ましい。内水相の割合は、本発明のW/O/W型複合エマルション全体に対して好ましくは15〜75%、より好ましくは25〜60%、さらに好ましくは30〜50%が望ましい。内水相と外水相の総量は好ましくは70〜95%、より好ましくは75〜93%、さらに好ましくは80〜90%が望ましい。この範囲内ではエマルション化が良好であるので好ましい。
なお、本明細書において特に記載しない限り、“%”は質量%を表す。
(2) Secondary emulsification While stirring an external aqueous phase solution (preferably containing a hydrophilic surfactant) with a homomixer under a temperature condition of 45 to 70 ° C., particularly preferably 50 to 65 ° C. (1 The W / O emulsion obtained in (1) is a W / O emulsion / outer aqueous phase = 30/70 to 80/20, preferably 40/60 to 70/30, more preferably 45/55 to 60/40. The W / O / W type composite emulsion is prepared by adding to the outer aqueous phase so that the mass ratio is as follows. The emulsification conditions are preferably selected as appropriate so that the composite particles once generated are not destroyed, but it is preferable to emulsify for 20 to 90 minutes at a rotational speed of approximately 500 to 3000 rpm.
With the configuration of the present invention, it is possible to increase the water content of the inner aqueous phase. The mixing mass ratio of the inner aqueous phase and the oil phase of the W / O type emulsion as the dispersoid is: inner aqueous phase / oil phase = preferably 50/50 to 90/10, more preferably 60/40 to 85/15, More preferably, 70/30 to 80/20 is desirable. Within this range, a preferable feeling of use of the preparation can be obtained, which is preferable.
The mass ratio of the W / O emulsion to the outer aqueous phase as a dispersion medium is W / O emulsion / outer aqueous phase = preferably 30/70 to 80/20, more preferably 40/60 to 70/30, More preferably, 45/55 to 60/40 is desirable. Within this range, the production rate and stability of the emulsion of the present invention are good, which is preferable. The proportion of the inner aqueous phase is preferably 15 to 75%, more preferably 25 to 60%, and still more preferably 30 to 50% with respect to the entire W / O / W composite emulsion of the present invention. The total amount of the inner aqueous phase and the outer aqueous phase is preferably 70 to 95%, more preferably 75 to 93%, and still more preferably 80 to 90%. Within this range, emulsification is good, which is preferable.
Unless otherwise specified in the present specification, “%” represents mass%.
本発明のW/O/Wエマルションには、上記の他、通常W/O/W型複合エマルションに用いられる以下の成分を含有することが好ましい。
親油性界面活性剤(1次乳化で用いる乳化剤)として好ましいのは、グリフィンによるHLBが10以下、より好ましくは7以下、さらに好ましくは6以下の親油性界面活性剤である。一般外用剤、化粧品に配合され、W/O型エマルションを形成する親油性界面活性剤を使用することができる。例えば、ソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、プロピレングリコール脂肪酸エステル、親油性ポリグリセリン脂肪酸エステル、親油性ポリオキシエチレンヒマシ油、親油性ポリオキシエチレン硬化ヒマシ油、親油性ショ糖脂肪酸エステル等があげられるが、特にこれらに限定されない。これらのうち、ソルビタン脂肪酸エステル、親油性ポリオキシエチレン硬化ヒマシ油が好ましい。これらの親油性界面活性剤は単独で使用しても2種以上を併用してもよい。親油性界面活性剤の配合量は、その種類や油相成分によって異なるが、油相に対して好ましくは3〜50%、より好ましくは5〜40%、W/O/W型複合エマルション全体に対しては好ましくは1〜10%、より好ましくは2〜8%が望ましい。
In addition to the above, the W / O / W emulsion of the present invention preferably contains the following components that are usually used in W / O / W type composite emulsions.
Preferred as the lipophilic surfactant (emulsifier used in the primary emulsification) is a lipophilic surfactant having an HLB by Griffin of 10 or less, more preferably 7 or less, and even more preferably 6 or less. Lipophilic surfactants that are blended in general external preparations and cosmetics to form W / O type emulsions can be used. Examples include sorbitan fatty acid ester, glycerin fatty acid ester, propylene glycol fatty acid ester, lipophilic polyglycerin fatty acid ester, lipophilic polyoxyethylene castor oil, lipophilic polyoxyethylene hydrogenated castor oil, lipophilic sucrose fatty acid ester, and the like. However, it is not particularly limited to these. Of these, sorbitan fatty acid esters and lipophilic polyoxyethylene hydrogenated castor oil are preferred. These lipophilic surfactants may be used alone or in combination of two or more. The blending amount of the lipophilic surfactant varies depending on the type and oil phase component, but is preferably 3 to 50%, more preferably 5 to 40%, and the entire W / O / W type composite emulsion with respect to the oil phase. On the other hand, it is preferably 1 to 10%, more preferably 2 to 8%.
親水性界面活性剤(2次乳化で用いる乳化剤)として、一般外用剤、化粧品に配合され、O/W型エマルションを形成する親水性界面活性剤を使用することができる。例えば、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、親水性ポリグリセリン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、親水性ポリオキシエチレンヒマシ油、親水性ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンステロール、親水性ポリエチレングリコール脂肪酸エステル、親水性ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレン重合体、親水性ショ糖脂肪酸エステル等があげられるが、特にこれらに限定されない。これらのうち、親水性ポリエチレングリコール脂肪酸エステル、親水性ポリオキシエチレンアルキルエーテルが好ましい。これらの親水性界面活性剤は、単独で使用しても2種以上を併用してもよい。親水性界面活性剤の配合量は、その種類や油相成分および親油性界面活性剤の配合量によって異なるが、外水相に対して好ましくは0.3〜10%、より好ましくは0.5〜8%、さらに好ましくは1〜6%、W/O/W型複合エマルション全体に対しては、好ましくは0.3〜5%、より好ましくは0.5〜3%が望ましい。このときW/O型エマルションの生成に用いた親油性界面活性剤を可溶化させない範囲内の配合量が必要であり、両者の配合比は、親油性界面活性剤/親水性界面活性剤=0.5/1〜20/1、好ましくは0.8/1〜15/1、さらに好ましくは1/1〜10/1が望ましい。 As a hydrophilic surfactant (emulsifier used in secondary emulsification), a hydrophilic surfactant that is blended in general external preparations and cosmetics to form an O / W type emulsion can be used. For example, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene glycerin fatty acid ester, hydrophilic polyglycerin fatty acid ester, polyoxyethylene sorbit fatty acid ester, hydrophilic polyoxyethylene castor oil, hydrophilic polyoxyethylene hydrogenated castor oil, polyoxyethylene Sterol, hydrophilic polyethylene glycol fatty acid ester, hydrophilic polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene polyoxypropylene polymer, hydrophilic sucrose fatty acid ester, etc. However, it is not limited to these. Of these, hydrophilic polyethylene glycol fatty acid esters and hydrophilic polyoxyethylene alkyl ethers are preferred. These hydrophilic surfactants may be used alone or in combination of two or more. The blending amount of the hydrophilic surfactant varies depending on the type and blending amount of the oil phase component and the lipophilic surfactant, but is preferably 0.3 to 10%, more preferably 0.5 to 8% with respect to the outer water phase, More preferably, it is 1 to 6%, and preferably 0.3 to 5%, more preferably 0.5 to 3% with respect to the whole W / O / W type composite emulsion. At this time, a blending amount within a range not solubilizing the lipophilic surfactant used to produce the W / O type emulsion is necessary, and the blending ratio of both is lipophilic surfactant / hydrophilic surfactant = 0.5. / 1 to 20/1, preferably 0.8 / 1 to 15/1, more preferably 1/1 to 10/1.
本発明は、水相成分に有効成分を含有させることにより、医薬製剤や化粧料に供することができる。水溶性の有効成分としては、尿素、グリセリン等の保湿成分、アスコルビン酸、パントテン酸等のビタミン類、塩酸ジブカイン、塩酸リドカイン等の局所麻酔剤、塩酸ジフェンヒドラミン、ホモスルファミン等の抗ヒスタミン剤、グアイアズレン等の抗炎症成分を挙げることができる。異種の水溶性成分を内水相と外水相とそれぞれに配合することもできる。有効成分の種類は上記に限定されるものではなく適宜選択される。
また、本発明の効果を損なわない範囲で、通常外用剤に配合される基剤成分を必要に応じて適宜配合できる。例えばパラベン類、安息香酸類、塩化ベンザルコニウム、塩化ベンゼトニウム、塩化セチルピリジニウム、塩化アルキルトリメチルアンモニウム、クロロブタノール、フェノキシエタノール等の防腐剤、トコフェロール、エリソルビン酸、没食子酸プロピル、BHT、BHA、NDGA等の抗酸化剤、香料を挙げることができる。
The present invention can be used for pharmaceutical preparations and cosmetics by containing an active ingredient in an aqueous phase component. As water-soluble active ingredients, moisturizing ingredients such as urea and glycerin, vitamins such as ascorbic acid and pantothenic acid, local anesthetics such as dibucaine hydrochloride and lidocaine hydrochloride, antihistamines such as diphenhydramine hydrochloride and homosulfamine, and anti-histamines such as guaiazulene Mention may be made of inflammatory components. Different water-soluble components can be blended in the inner aqueous phase and the outer aqueous phase, respectively. The kind of active ingredient is not limited to the above, but is appropriately selected.
Moreover, the base component normally mix | blended with an external preparation can be mix | blended suitably as needed in the range which does not impair the effect of this invention. For example, antiseptics such as parabens, benzoic acids, benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, alkyltrimethylammonium chloride, chlorobutanol, phenoxyethanol, anticoagulants such as tocopherol, erythorbic acid, propyl gallate, BHT, BHA, NDGA, etc. An oxidizing agent and a fragrance | flavor can be mentioned.
下記の表1〜4に示した実施例及び比較例の組成でW/O/W型複合エマルションを調製し、その生成率と各温度領域における保存安定性、および得られたW/O/W型複合エマルションの使用感を評価した。
(調製法)
内水相、油相、外水相を個別に調製し、それぞれを70℃〜80℃に加温攪拌し、均一に溶解させた。70℃〜80℃の温度下でホモミキサーを用いて4000 rpm〜5000 rpmで油相を攪拌しながら、内水相をゆっくり添加していき、5〜10分間乳化し、W/O型エマルションを得た。続いて外水相を500〜1000 rpmで攪拌しながら、該W/O型エマルションをゆっくり添加していき30〜60分間乳化し、W/O/W型複合エマルションを得た。
(生成率)
W/O/W生成率(%)は、マーカー物質として塩化カリウムを内水相に配合してエマルションを調製後、透析により外水相に存在する塩素イオン濃度をイオンメーターで測定し求めた。生成率100%とは、マーカー物質がすべて内水相中に封入された状態であり、生成率0%とは、マーカー物質がすべて外水相に移行しO/W型の転相した状態である。
生成率は、下記の5段階で評価し、◎○△を高い生成率と判断した。
(生成率(%):85%以上:◎、70〜85%:○、60〜70%:△、50〜60%:▲、50%未満:×、エマルション化不可:−)
W / O / W type composite emulsions were prepared with the compositions of Examples and Comparative Examples shown in Tables 1 to 4 below, the production rate and storage stability in each temperature range, and the obtained W / O / W The feeling of use of the mold composite emulsion was evaluated.
(Preparation method)
An inner aqueous phase, an oil phase, and an outer aqueous phase were separately prepared, and each was heated and stirred at 70 ° C. to 80 ° C. to be uniformly dissolved. While stirring the oil phase at 4000 rpm to 5000 rpm using a homomixer at a temperature of 70 ° C. to 80 ° C., slowly add the inner aqueous phase and emulsify for 5 to 10 minutes. Obtained. Subsequently, while stirring the outer aqueous phase at 500 to 1000 rpm, the W / O emulsion was slowly added and emulsified for 30 to 60 minutes to obtain a W / O / W composite emulsion.
(Production rate)
The W / O / W production rate (%) was obtained by preparing an emulsion by mixing potassium chloride as a marker substance in the inner aqueous phase, and then measuring the chloride ion concentration present in the outer aqueous phase by dialysis with an ion meter. A production rate of 100% means that all marker substances are enclosed in the inner aqueous phase, and a production rate of 0% means that all marker substances have moved to the outer aqueous phase and have undergone O / W phase inversion. is there.
The production rate was evaluated according to the following 5 levels, and ◎ ○ Δ was judged as a high production rate.
(Production rate (%): 85% or more: ◎, 70 to 85%: ○, 60 to 70%: △, 50 to 60%: ▲, less than 50%: ×, emulsification not possible:-)
(安定性)
保存安定性は、調製したエマルションをスクリューキャップ付きサンプル管に入れ、所定条件下で保存後、状態を観察し評価した。
安定性は、下記の5段階で評価し、◎○△を安定なレベルと判断した。
(保存安定性:変化なし:◎、やや粘度低下:○、粘度低下:△、表面に僅かに油しみだし:▲、相分離:×)
なお、凍結復元性の評価は、エマルションを−20℃に1日保存し凍結させた後、室温に3日間静置し、状態を観察して評価した。
(使用感)
下記の実施例および比較例のW/O/W型複合エマルションについて、20人のパネラーに対して使用テストを実施した。
方法は、20℃/50%RHの恒温恒湿下で15分間安静にした後、前腕内側に所定量(0.5mL)の検体を塗布し、塗布時ののびの良さ、肌へのなじみの良さ、塗布後のさっぱり感、べたつき感のなさ、総合評価の5項目について5段階で評点付けし、20人の合計点で評価した。
(各項目の評価基準:非常に良好:5点、良好:4点、普通:3点、悪い2点、非常に悪い:1点)
使用感は、下記の5段階で評価し、◎○△を良好な使用感と判断した。
(使用感点数評価:85点以上:◎、70〜85点:○、60〜70点:△、50〜60点:▲、50点未満:×)
(Stability)
Storage stability was evaluated by putting the prepared emulsion in a sample tube with a screw cap and storing it under a predetermined condition, and then observing the state.
The stability was evaluated according to the following 5 grades, and ◎ ○ △ was judged to be a stable level.
(Storage stability: no change: ◎, slightly reduced viscosity: ◯, reduced viscosity: △, slightly exuded on the surface: ▲, phase separation: ×)
The evaluation of freeze-restoration was evaluated by storing the emulsion at −20 ° C. for 1 day and freezing it, then allowing it to stand at room temperature for 3 days, and observing the state.
(Usage feeling)
Using the W / O / W type composite emulsions of the following examples and comparative examples, a use test was conducted on 20 panelists.
The method is to rest for 15 minutes under constant temperature and humidity of 20 ° C./50% RH, and then apply a predetermined amount (0.5 mL) of the sample to the inner side of the forearm. The five items of goodness, freshness after application, no stickiness, and overall evaluation were rated on a five-point scale, and the total score of 20 people was evaluated.
(Evaluation criteria for each item: very good: 5 points, good: 4 points, normal: 3 points, bad 2 points, very bad: 1 point)
The feeling of use was evaluated according to the following five grades, and ◎ ○ △ was judged as a good feeling of use.
(Score evaluation: 85 points or more: ◎, 70-85 points: ○, 60-70 points: △, 50-60 points: ▲, less than 50 points: ×)
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009053630A JP4731610B2 (en) | 2009-03-06 | 2009-03-06 | W / O / W type composite emulsion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009053630A JP4731610B2 (en) | 2009-03-06 | 2009-03-06 | W / O / W type composite emulsion |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP33735099A Division JP4478264B2 (en) | 1999-11-29 | 1999-11-29 | W / O / W type composite emulsion |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009132937A JP2009132937A (en) | 2009-06-18 |
JP4731610B2 true JP4731610B2 (en) | 2011-07-27 |
Family
ID=40865097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009053630A Expired - Fee Related JP4731610B2 (en) | 2009-03-06 | 2009-03-06 | W / O / W type composite emulsion |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4731610B2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000288308A (en) * | 1999-04-09 | 2000-10-17 | Sannopuko Kk | W/o/w type defoamer composition |
JP2001025360A (en) * | 1999-07-15 | 2001-01-30 | Mitsubishi-Kagaku Foods Corp | W/o/w type emulsion composition and its production |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60199833A (en) * | 1984-03-26 | 1985-10-09 | Meiji Milk Prod Co Ltd | Preparation of w/o/w-type composite emulsion for pharmaceutical, cosmetic, etc. |
JP3789027B2 (en) * | 1997-07-17 | 2006-06-21 | 株式会社資生堂 | W / O / W type composite emulsion |
-
2009
- 2009-03-06 JP JP2009053630A patent/JP4731610B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000288308A (en) * | 1999-04-09 | 2000-10-17 | Sannopuko Kk | W/o/w type defoamer composition |
JP2001025360A (en) * | 1999-07-15 | 2001-01-30 | Mitsubishi-Kagaku Foods Corp | W/o/w type emulsion composition and its production |
Also Published As
Publication number | Publication date |
---|---|
JP2009132937A (en) | 2009-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018184516A1 (en) | Moisturizing composition and application thereof in preparation of moisturizing cosmetic product | |
TWI459969B (en) | External composition for skin | |
Li et al. | In vitro and in vivo evaluation of a simple microemulsion formulation for propofol | |
WO2013108513A1 (en) | Liquid cosmetic | |
JP2009149624A (en) | Cosmetic for skin | |
CN109464306A (en) | Mild inirritative makeup remover and preparation method thereof | |
JP2003292414A (en) | Liposoluble component-stabilized composition and cosmetic formulated with the composition and method for stabilizing liposoluble component | |
KR20090057044A (en) | Emulsion composition with good feeling of use | |
KR100732728B1 (en) | Emulsion cosmetic composite of low viscocity | |
EP2617410B1 (en) | Oil-in-water type cosmetic | |
JP4478264B2 (en) | W / O / W type composite emulsion | |
Falusi et al. | Investigation of the effect of polymers on dermal foam properties using the QbD approach | |
KR20120031879A (en) | Emulsion composition | |
JP4731610B2 (en) | W / O / W type composite emulsion | |
JP2024114984A (en) | Emulsion composition | |
JP4822092B2 (en) | W / O / W type composite emulsion | |
JP2006290762A (en) | Oil-in-water emulsified composition | |
JP7276784B2 (en) | Redispersible two-layer cosmetic | |
CN112533582B (en) | Gel particles and external preparation for skin containing the same | |
JP4659510B2 (en) | W / O / W type emulsion composition | |
EP2691080A1 (en) | Menthol liquids composition | |
KR20230124615A (en) | aqueous emulsion | |
JP2017002011A (en) | Polymer hydro gel covered o/w emulsion, production method thereof, and surfactant composition for preparing the o/w emulsion | |
JP4285859B2 (en) | W / O / W type composite emulsion | |
CN115040437B (en) | Cosmetic composition in the form of an O/W emulsion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090406 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101216 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110214 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110217 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110314 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110414 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110419 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140428 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4731610 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |